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Ca2+ signals  are  central  to  the stimulation  of  insulin  secretion  from  pancreatic  -cells  by glucose  and
other  agents,  including  glucagon-like  peptide-1  (GLP-1).  Whilst  Ca2+ inﬂux  through  voltage-gated  Ca2+
channels  on the  plasma  membrane  is  a key  trigger  for  glucose-stimulated  secretion,  mobilisation  of  Ca2+
from  acidic  stores  has  been  implicated  in  the  control  of  more  localised  Ca2+ changes  and  membrane
potential.  Nicotinic  acid adenine  dinucleotide  phosphate  (NAADP),  generated  in  -cells in  response  to
high glucose,  is a potent  mobiliser  of  these  stores,  and  has  been  proposed  to  act through  two  pore  channels
(TPC1  and  TPC2,  murine  gene  names  Tpcn1  and  Tpcn2).  Whilst  the  role  of  TPC1  in the  control  of Ca2+
mobilisation  and  insulin  secretion  was  recently  conﬁrmed,  conﬂicting  data  exist  for  TPC2. Here,  we  used
the  selective  and  efﬁcient  deleter  strain,  Ins1Cre  to  achieve  -cell  selective  deletion  of the  Tpcn2  gene
in  mice.  Tpcn2  KO  mice  displayed  normal  intraperitoneal  and  oral  glucose  tolerance,  and  glucose-
stimulated  Ca2+ dynamics  and insulin  secretion  from  islets  were  similarly  normal.  GLP-1-induced  Ca2+AADP increases  involved  an increase  in  oscillation  frequency  from  4.35  to 4.84  per  minute  (p = 0.04)  at  8  mM
glucose,  and  this  increase  was  unaffected  by the  absence  of Tpcn2.  The  current  data  thus  indicate  that
TPC2  is not  absolutely  required  for  normal  glucose-  or incretin-stimulated  insulin  secretion  from  the
-cell.  Our  ﬁndings  suggest  that  TPC1,  whose  expression  tended  to  increase  in Tpcn2  null  islets,  might  be
sufﬁcient  to support  normal  Ca2+ dynamics  in response  to stimulation  by nutrients  or incretins.
ublis© 2016  The  Authors.  P
. Introduction
The pancreatic islet -cell is an important model for the study
f fuel sensing and stimulus-secretion coupling [1,2]. Derangement
f normal -cell function [3], as well as a decrease in overall -cell
ass [4,5], underlie insulin deﬁciency in type 2 diabetes [1,6,7] a
isease which now affects more than 8% of the adult population
orldwide [8].
Classically, elevated blood glucose levels are believed to stim-
late insulin secretion through an increased cytosolic ATP:ADP
atio [9,10] leading to closure of ATP-sensitive K+ channels (KATP)
11] and enhanced Ca2+ inﬂux through voltage-dependent Ca2+
hannels (VDCCs). Whilst substantial pharmacological [11] and
Abbreviations: AUC, area under the curve; [Ca2+]i, intracellular free Ca2+ ion
oncentration; GLP-1, glucagon-like peptide-1; IPGTT, OGTT, intraperitoneal and
ral glucose tolerance test; NAADP, nicotinic acid adenine dinucleotide phosphate;
PC1, TPC2, two  pore channels 1 and 2.
∗ Corresponding author.
E-mail address: g.rutter@imperial.ac.uk (G.A. Rutter).
ttp://dx.doi.org/10.1016/j.ceca.2015.12.004
143-4160/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article uhed  by Elsevier  Ltd. This  is an open  access  article  under  the  CC BY  license
(http://creativecommons.org/licenses/by/4.0/).
genetic [12,13] evidence supports this model, it is undoubtedly
incomplete, not least because deletion of KATP channel subunits
(SUR1/ABCC8 and Kir6.2/KCNJ11)  does not render -cells wholly
glucose-unresponsive [14,15]. Indeed, it is increasingly accepted
that an integration of nutrient, neurotransmitter and hormonal
signals is necessary for the induction of insulin release in vivo [1,2].
Internal Ca2+ stores, including those associated with the endo-
plasmic reticulum (ER) [16], and acidic stores, are also known to
modulate intracellular free Ca2+ ([Ca2+]i) signals in -cells [2]. Of
note, alkalinisation of acidic stores by inhibition of the Vo-ATPase
with Baﬁlomycin A1 impedes glucose-induced [Ca2+]i responses in
these cells [17,18]. Nicotinic acid adenine dinucleotide (NAADP)
is an important second messenger which has been implicated
in the recruitment of acidic stores for the generation of [Ca2+]i
signals. Produced by the endosomal/cell surface-located enzyme
CD38 via a base exchange reaction [19], NAADP is generated in
-cells in response to glucose [20], and the incretin hormone
glucagon-like peptide-1 (GLP-1) [21]. Whilst the latter G-protein
receptor-coupled hormone potently stimulates insulin secretion at
permissive glucose concentrations, allowing the development of
incretin-based therapies for type 2 diabetes [22–24], the impact of
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Table 1
List of primers. qRT-PCR primers were designed to span an exon boundary in order
to  prevent interaction with genomic DNA as opposed to cDNA. Tpcn2 ﬂox primers
ﬂank a loxP site, producing differential product sizes for ﬂoxed and wild type alleles.
Excision event primers ﬂank both loxP sites allowing for conﬁrmation of the Cre
excision event.
qRT-PCR Tpcn2 F-ATGATGAAGAAGACCCTGAAGTG
R-TGTGCTTCATCCTTCTCACC
-actin F-CGAGTCGCGTCCACCC
R-CATCCATGGCGAACTGGTG
Genotyping Tpcn2 ﬂox F-ATTCTGGGCTGCTACTGTGG
R-GTTGGTCCTCCTAGGCTGTG
Ins1cre F-ATGTCCAATTTACTGACCG
R-CGCCGCATAACCAGTGAAACM.C. Cane et al. / Cell
LP-1 on -cell Ca2+ dynamics is less well established and appears
o be species dependent [25–27].
Whilst also a matter of debate, consensus is building that one or
ore of the two pore channel subtypes (TPC) serves as the putative
AADP receptor Ca2+-release channel. Nevertheless, it is also possi-
le that TPCs form one part of a channel complex that also includes
 distinct NAADP-binding protein. Expressed on endo-lysosomal
ompartments, TPCs (gene name TPCN) have been implicated in the
eneration of NAADP-mediated Ca2+ signals in - and other cells.
hus, TPC2 expression renders NAADP-unresponsive cells respon-
ive [28], and expression of cell surface targeted TPCs allows NAADP
o induce Ca2+ inﬂux [29]. Furthermore, both the rodent Tpcn2 and
he orthologous human TPCN2 gene have been identiﬁed as poten-
ial causal genes for diabetes-associated traits [30].
Despite this body of data indicating an important role of TPC2
n Ca2+ signalling in -cells, knock out of the Tpcn2 gene in various
nimal models has shown divergent effects. For example, global
eletion of the Tpcn2 gene in the mouse through the use of a
ene trap vector renders pancreatic -cells unresponsive to NAADP
ither through use of the cell permeable analogue NAADP-AM or
hrough introduction of NAADP directly through the patch pipette
17,28]. Similarly, glucose-induced Ca2+ signals are also somewhat
mpaired in Tpcn2−/− mice, although they are not fully ablated [17].
onetheless, glucose-induced insulin secretion was barely affected
nd glucose tolerance was not abnormal in Tpcn2−/− animals [17].
n the other hand, Tpcn1−/− mice showed clear differences in both
arameters [17]. Of note, although the Tpcn2−/− mice used in a
ecent study by Wang et al. [18] similarly failed to show any abnor-
alities in terms of responses to NAADP, the truncation in this allele
ay  still enable the expression of a functional TPC2 protein [31].
In light of these discrepancies, we have generated -cell-speciﬁc
pcn2 knockout mice by crossing animals harbouring a ﬂoxed exon
f the Tpcn2 gene to knock-in mice expressing Cre recombinase at
he endogenous Ins1 locus [32,33]. This strategy results in efﬁcient
∼95%) recombination in -cells [32,33] (Johnston et al, unpub-
ished results) throughout the islet. Furthermore, and in contrast
o other currently-available insulin promoter-driven Cres, notably
IP2Cre [34–36], recombination with the Ins1Cre strain is not com-
licated either by off-target events including recombination in the
rain [37] nor by the simultaneous ectopic expression of human
rowth hormone (hGH) in the -cell.
This approach has enabled us to study further the role of TPC2 in
he -cell whilst eliminating confounding effects which may  result
rom the deletion of the Tpcn2 gene in other tissues. After con-
rming ablation of Tpcn2 expression we have used this model to
etermine the cell autonomous role of TPC2 in the -cell, focussing
n glucose homeostasis, insulin secretion and the regulation of Ca2+
ynamics by glucose and incretins.
. Methods
.1. Animal origin and maintenance
Mice heterozygous for the ﬂoxed allele of the Tpcn2 gene
exon 6 ﬂanked by loxP sites) were obtained from the Euro-
ean conditional mouse mutagenesis program (EUCOMM)
ia MRC  Harwell, U.K. Mice bore the “Tm1c” (http://www.
ousephenotype.org/about-ikmc/eucomm-program/eucomm-
argeting-strategies)allele (Tpcn2tm1c(EUCOMM)Hmgu) and were
rossed with Ins1Cre-expressing animals [32]. The subsequent
itters were back-crossed to generate Tpcn2ﬂ/ﬂ:Ins1Cre+/− (referred
o as ‘KO’) and Tpcn2ﬂ/ﬂ:Ins1Cre−/− (referred to as ‘control’) mice.
ffspring were bred together to generate litters with ∼50% WT
ice and ∼50% -cell speciﬁc Tpcn2-deleted mice. Animals bearingExcision event F-CTGCTACTGTGGGTGGTATATGG
R-CAATGTTATTTGAACTGATGGCGAG
the Ins1Cre transgene alone displayed no abnormalities in glucose
tolerance, insulin secretion or -cell mass [32].
Animals were maintained on a C57/BL6 background and 2 to 4
mice were housed per individually-ventilated cage in a pathogen-
free facility. Mice were kept under a 12 h light/dark cycle and fed a
regular chow diet (Lillico Biotechnology). All in vivo experiments
were performed on male mice and islets were isolated from an
equal number of male and female mice. All animal experiments
were approved by the UK Home Ofﬁce under the Animals (Scientiﬁc
Procedures) Act 1986 (PPL 70/7349).
2.2. qRT-PCR
Approximately 100 freshly isolated islets were used for RNA
extraction using TRIzol reagent (Invitrogen) and cDNA was gen-
erated using a high capacity reverse transcription kit (Applied
Biosystems) according to the manufacturer’s instructions. SYBR
Green qRT-PCR was  performed as previously described (REF) and -
Actin was  used as the reference gene. See Table 1 for list of primers.
2.3. Glucose tolerance tests
Mice were fasted overnight before i.p. injection or oral gavage
of 30% glucose in water to a dose of either 1 g/kg or 3 g/kg. Blood
was sampled from the tail vein at 0, 15, 30, 60 and 120 min  and
glycaemia measured using an automatic glucometer (Accu-chek,
Roche).
2.4. Insulin secretion
Islets were isolated by collagenase dissociation as described pre-
viously [38] and ∼50 islets were perifused with Krebs-HEPES buffer
(in mM,  130 NaCl, 3.6 KCl, 0.5 NaH2PO4, 2 NaHCO3, 1.5 CaCl2, 1.2
MgCl2, 3 D-glucose, 10 HEPES, 0.5 MgSO4, pH 7.4 substituted with
0.1% bovine serum albumin) at a rate of 500 l min−1 at 37 ◦C in
a custom-built chamber. Perifusate was  collected in 30 s intervals.
Islets were primed with Krebs medium containing 3 mM glucose
for 30 min  prior to the experiment and glucose was  increased to
16.9 mM 2 min  after the initial collection. Islets were then frozen
in 10 ml  acidic ethanol (1.5% 1 M HCl, 75% EtOH, 0.1% Triton X-
100) until assayed for total insulin content. The latter samples
were diluted 1:100 whilst secreted insulin samples were assayed
undiluted using an HTRF insulin assay kit (Cisbio assays) and a
PHERAstar reader (BMG), following the manufacturer’s guidelines.
2.5. Calcium imagingExperiments were performed essentially as previously
described [26]. In brief, islets were loaded with 10 M Fluo-8
AM (Abcam) dissolved in DMSO (0.01% wt/vol) in Krebs-HEPES
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Fig. 1. (A) Schematic of the ﬂoxed allele of Tpcn2 showing the location of loxP sites ﬂanking exon 6 and the target sites of primers used in (C). (B) The excision event resulting
from  the cross with Ins1Cre mice as demonstrated by the removal of the critical region containing exon 6. (C) Relative expression of Tpcn2 in control (black) and -cell-speciﬁc
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eeks  of age. (For interpretation of the references to colour in this ﬁgure legend, t
sed  for PCR and qRT-PCR.
uffer for 45 min  at 37 ◦C. Islets were visualised using a Zeiss
xiovert confocal microscope and perifused continuously at
4–36 ◦C with Krebs-HEPES buffer containing relevant concen-
rations of glucose and GLP-1. Fluo-8 was excited with a 491 nm
aser and emitted light collected at 525 nm.  VolocityTM software
Perkin–Elmer) was used for imaging and analysis. Traces were
ormalised to the initial ﬂuorescence (F/F0).
.6. Statistics
Data were analysed using GraphPad PRISM 6.0 software and
igniﬁcance was tested using unpaired Student’s two-tailed t-tests
ith Bonferroni post-tests for multiple comparisons, or two-way
NOVA as indicated. p < 0.05 was considered signiﬁcant and errors
ignify mean ± SEM.
. Results
.1. Unaltered glucose tolerance after targeted deletion of Tpcn2
rom ˇ-cells
To delete TPC2 speciﬁcally from the pancreatic -cell, mice bear-
ng alleles of the Tpcn2 gene with loxP sites ﬂanking exon 6 were
rossed to mice bearing the Ins1Cre transgene [32] (Fig. 1A). In the
rst instance, we conﬁrmed the Cre excision event by PCR. Primers
anking the loxP sites were expected to generate a 1055 bp frag-
ent in the control islets, and a smaller fragment of 215 bps in
he KO islets, after the excision event has taken place. The cor-
esponding bands can be seen in Fig. 1B. Secondly, we conﬁrmed
nock down of the expression of Tpcn2 by qRT-PCR. Relative expres-
ion of the Tpcn2 transcript from KO islets was decreased to ∼50%
f control levels. This reduction is compatible with essentiallyon. (D) Changes in the weight of control (black) and KO (blue) animals from 8 to 20
der is referred to the web version of this article.) See Table 1 for details of primers
complete deletion from -cells, assuming a -: -cell ratio of ∼3:1
[39] and a ratio of Tpcn2 mRNA of 1:3 in -: -cells [40]. Tpcn1
mRNA levels showed a slight tendency towards an increase in Tpcn2
null islets (p = 0.147, Fig. 1C).
Tpcn2 KO mice were indistinguishable from littermate con-
trol animals by visual inspection, and displayed normal growth
and weight changes (Fig. 1D). Glucose tolerance was investigated in
these mice by both intraperitoneal (IPGTT) and oral (OGTT) admin-
istration of the sugar, the latter allowing exploration of the incretin
effect on insulin secretion. Mice underwent IPGTTs at 8–12 weeks,
and then again at 16–20 weeks of age by administration of 1 g/kg
glucose. Whilst a small decrease in glucose tolerance was observed
between the younger and older mice, no signiﬁcant differences
were observed between the Tpcn2 KO mice and their littermate
controls in either age group (Fig. 2A, B). Similarly, no signiﬁcant
difference between genotypes was observed during either OGTT
at 12–16 weeks (performed using a higher concentration of 3 g/kg
glucose) or at 20–24 weeks of age (Fig. 2C, D).
3.2. Normal glucose-induced Ca2+ dynamics and insulin secretion
in ˇTpcn2 KO mouse islets
Having demonstrated a lack of any effect of -cell-selective
TPC2 ablation on glucose tolerance in vivo, where compensatory
effects might conceivably obscure changes in -cell glucose respon-
siveness, we performed studies using islets ex vivo to determine
whether a more subtle role of TPC2 deletion might be unmasked.
The effect of TPC2 deletion in -cells on Ca2+ signals was investi-
gated by live ﬂuorescence microscopy on isolated islets loaded with
the Ca2+ indicator Fluo-8. Peak-plateau responses in intracellular
free Ca2+ ([Ca2+]i) were generated in whole islets by the addition
of high (17 mM)  glucose after a period of exposure to low (3 mM)
M.C. Cane et al. / Cell Calcium 59 (2016) 32–40 35
Fig. 2. Glucose tolerance tests of control and Tpcn2 KO mice. Glucose tolerance after intraperitoneal (ip) glucose injection (A, B) or oral glucose via gavage (C, D) of male
m mice (
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mice.  Mice were given 1 g/kg glucose with the exception of the 12–16-week OGTT 
nder  the curve (AUC) analysis as shown in the inset bar graphs and the number of 
tatistically signiﬁcant differences were observed.
lucose. Regions of interest were drawn around the whole islet to
bserve the coordinated response to increased glucose (Fig. 3 A–G).
PC2 deletion had no obvious effect on the above Ca2+ responses,
fter analysis of both the peak and the area under curve (AUC). Like-
ise, changes in membrane potential after high glucose treatment
ere similarly not affected by the absence of TPC2 (Sones, W and
R, results not shown, n = 3).
Insulin secretion from isolated islets was  next monitored
ynamically over time using a custom built perifusion apparatus.
nsulin secretion was induced by the addition of 17 mM glucose
fter a period of exposure to low glucose (3 mM).  Insulin secre-
ion began immediately after the increase in glucose concentration
nd achieved a peak rate of secretion of approximately 0.14% of
he total insulin content per minute. Secretion then slowed to
 plateau around 0.07% of total insulin per minute. The absence
f TPC2 from -cells resulted in no evident change in either the
eak rate of this response nor in the overall insulin secreted,
s represented by analysis of the area under the curve (Fig. 3
–J).
.3. Normal incretin-induced Ca2+ dynamics and insulin
ecretion in ˇTpcn2 KO mouse islets
We  next used the same techniques to determine whether TPC2
ay  contribute to incretin-regulated Ca2+ dynamics. Islets wereC) which were given a higher dose of 3 g/kg. Experiments were quantiﬁed by area
sed in each experiment is shown in white. Data are expressed as means ± SEM. No
stimulated ﬁrst with 11 mM glucose and additionally with 20 nM
GLP-1 eight minutes later. Addition of the incretin at this con-
centration of glucose did not lead to any signiﬁcant effect on
[Ca2+]i in control or KO islets (Fig. 4 A–C). However, and despite
not signiﬁcantly affecting Ca2+ signals, GLP-1 did induce a rapid
and signiﬁcant increase in the plateau of insulin secretion (Fig. 4
D–F), indicating that the ability of GLP-1 to increase insulin release
was via potentiation of Ca2+-dependent exocytosis but did not
result from an increase in [Ca2+]i beyond that produced by glu-
cose alone. TPC2 ablation did not affect the secretory response to
GLP-1, nor insulin secretion in response to 8 mM glucose alone, as
conﬁrmed by area under the curve analysis and measurement of
peak responses.
3.4. Subtle changes in GLP-1-induced Ca2+ transients during
moderate glucose stimulation of ˇTpcn2 KO islets are
indistinguishable from control
In an attempt to investigate a more subtle role of GLP-1 in Ca2+
signalling and subsequently to investigate the role of TPC2 in this
response, we  induced stable Ca2+ oscillations in isolated mouse
islets by stimulating with 8 mM glucose. The resulting oscillations
were variable between islets as can be seen in the individual exam-
ple traces (Fig. 5A, B). The oscillations were also systemic across
the islet and not speciﬁc to individual cells or regions (Fig. 5C).
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Fig. 3. Glucose responsiveness of control and Tpcn2 KO islets. (A–G) Ca2+ responses to 17 mM glucose in control islets (blue) and -cell speciﬁc Tpcn2 KO islets (black).
Example Ca2+ responses (A, B), and corresponding images of basal and peak ﬂuorescence showing the global response over the whole islet (C, D) where scale bars correspond
to  20 m.  (E) Averaged response showing the mean ± SEM of Ca2+ traces. These data are quantiﬁed by area under curve analysis (F) and the average peak ﬂuorescence (G).
(H–J)  Insulin secretion from isolated islets from control (black) and beta cell speciﬁc Tpcn2 knock-out mice (blue). (H) Insulin secreted over time shown as mean ± SEM.
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he addition of GLP-1 after glucose administration increased the
requency of these oscillations without prompting any recruitment
f previously quiescent cells into activity (Fig. 5 A–C). Islets showed
arying responses to GLP-1 but a signiﬁcant number showed an
ncrease, as can be seen by the increase in frequency shown in (Fig. 5
–F). However, no effect of Tpcn2 deletion on this modulation of
a2+ oscillation frequency was observed.
. Discussion
.1. Role of TPC2 in the beta cellWe  describe here the impact on glucose homeostasis and
a2+ dynamics of -cell selective deletion of Tpcn2 in the mouse.
limination of TPC2 was conﬁrmed by demonstrating a reductionf the experiment by insulin secreted as a percentage of the total insulin content of
ments is shown on the bars in white. (For interpretation of the references to colour
in transcript level compatible with a selective loss from the -cell
compartment, as expected with the use of the efﬁcient and -cell-
selective Ins1Cre strain [32]. Conﬁrmation of knockdown at the
protein level was not possible since commercially available anti-
bodies proved to be non-speciﬁc in our hands (results not shown).
The use of pharmacological agents (e.g. Baﬁlomycin A1) to alka-
linise this compartment, or others (GPN) to osmotically destabilise
it, have provided evidence for the importance of the acidic com-
partment as a Ca2± store involved in -cell stimulus secretion
coupling [41] as well as in other cell types including neuronal
[42] and smooth muscle [43] cells. The speciﬁc role for NAADP
in accessing these stores has also been shown pharmacologically
using competitive inhibition of NAADP-sensing with the putative
NAADP-receptor antagonist Ned-19 [17,20]. The potential role of
the two-pore channel as either a direct or indirect component of
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Fig. 4. Effect of GLP-1 on control and Tpcn2 KO islets (A) Average Ca2+ responses showing mean ± SEM. (B, C) Quantiﬁcation of the area under the curve (AUC) and peak of
Ca2+ traces. (D) Insulin secretion from isolated islets from control (black) and Tpcn2 KO mice (blue). (E, F) Quantiﬁcation of insulin secretion during the period from 2 to
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he NAADP-receptive machinery has also been demonstrated by
everal groups [44–47] including ourselves [17,31].
However, it should be noted that technical differences between
tudies mean that the current literature from other cells types
annot necessarily be extrapolated directly to the -cell. Most
mportantly, pharmacological inhibition may  lead to off-target
ffects. This is especially the case when the function or integrity
f an entire organelle is disrupted, as in the case of Baﬁlomycin
1 or GPN, manoeuvres which have been shown to also block IP3-
nd cADPR-mediated signals in Jurkat T-lymphocytes [48]. Like-
ise, whole-body deletion of a gene which is expressed in other
etabolically relevant tissues could have signiﬁcant subsequent
ffects on islet function; the Tpcn (and particularly Tpcn2)  fam-
ly are particularly strongly expressed in hematopoetic lineages in
ice (bioGPS.org) and their deletion from these tissues might con-
eivably affect innate immunity or alter inﬂammatory status, with
ubsequent impacts on islet and -cell function [49].
We therefore chose in the present study to use (1) targeted
ene inactivation, achieved through LoxP-mediated recombina-
ion of ﬂoxed Tpcn2 alleles, and (2) investigations of -cell Ca2±
esponses in whole islets. The latter preparation provides a reliable
eans of studying robust and reproducible [Ca2+]i signals in the
bsence of changes in -cell physiology and responsiveness which
an accompany islet disruption [26,27]. Although the Ca2+ indicator
sed, Fluo-8, is not partitioned selectively into -cells, increases in
Ca2+]i in response to glucose (or GLP-1) are likely to be restricted
o these cells, and a small number of -cells, rather than -cells
hich comprise ∼20% of the islet [26].
Examined in this setting, loss of Tpcn2 exerted no apparent effect
n Ca2+ signals provoked by nutrients or incretin. Whilst this may 10 to 32 min  for the 11 mM glucose plus GLP-1-stimulated islets. The number of
 of the references to colour in this ﬁgure legend, the reader is referred to the web
seem to question previous ﬁndings on Tpcn2−/− mice, it should be
emphasised that our earlier studies involved the use of isolated -
cells [17]. It is therefore possible that the involvement of NAADP in
glucose responses may  be less susceptible to deletion of Tpcn2 in the
context of the intact islet, given the complex communication and
feedback mechanisms existing between -cells within the micro-
organ [50].
In contrast, and despite minimal effects of Tpcn2 deletion
on glucose tolerance, glucose-evoked Ca2+ responses and insulin
secretion [17], responses to infused NAADP were eliminated in
-cells from whole body Tpcn2−/− mice. The present data there-
fore suggest that such currents, activated by high NAADP, are
not required for normal Ca2+ oscillations in response to glu-
cose or GLP-1 (see Figs. 3–5). However, we  would note that the
present studies did not explore the impact of NAADP in Tpcn2
KO mouse islets and it is conceivable that these NAADP-regulated
currents persisted, perhaps as a result of up-regulation of Tpcn1
(Fig. 1C). Alternatively, smaller currents, which cannot be readily
detected by patch clamp electrophysiology, may  be critical and con-
tribute to local changes in membrane potential which regulate Ca2+
inﬂux.
It is conceivable that the tendency for increases in Tpcn1
expression after Tpcn2 deletion, as seen in Fig. 1C is sufﬁcient to
compensate for the absence of the latter, especially given that basal
levels of Tpcn1 mRNA in the islet are signiﬁcantly (>10-fold) higher
than those of Tpcn2 [17], as also observed in other tissues such as
liver [31]. Correspondingly, Tpcn1−/− mice show marked defects in
both glucose tolerance and in glucose-stimulated insulin secretion.
Thus, it is possible that signiﬁcant functional redundancy exists
between TPC1 and TPC2 in the -cell. Studies using mice deleted
38 M.C. Cane et al. / Cell Calcium 59 (2016) 32–40
Fig. 5. Effect of GLP-1 on Ca2+ oscillations in control and Tpcn2 KO islets. (A, B) Example traces of control islets (blue) and -cell-speciﬁc Tpcn2 KO islets (black), showing
Ca2+ responses to 8 mM glucose with the addition of GLP-1. Boxes in (B) indicate regions shown in (C). (C) Example Ca2+ oscillations before and after the addition of GLP-1
after  the 8 mM glucose response in a KO islet. The Ca2+ signal, as observed during a single oscillation (image capture at 2 s intervals) is apparent across the whole islet. The
increase in oscillation frequency is apparent between the upper (−GLP-1) and lower (+GLP-1) traces. Scale bar = 20 m. (D, E) Change in oscillation frequency upon GLP-1
stimulation normalised to the rate induced by 8 mM glucose. Oscillations were counted in a 5 min  window before and after GLP-1 addition and the red dotted line indicated
the  average increase. p < 0.05 for the effects of GLP-1 in each case. (F) Quantiﬁcation of the increase in oscillation frequency, showing no signiﬁcant difference between control
a n this
f
t
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n
(
[
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m
(
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i
e
t
s
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ind  Tpcn2 KO islets (mean ± SEM). (For interpretation of the references to colour i
or Tpcn1 alone or both alleles in these cells will be necessary to
est this hypothesis.
.2. GLP-1 and Ca2+ dynamics
In the physiologically relevant setting of the perifused whole
slet, we observed only rather subtle effects of GLP-1 on Ca2+ sig-
als induced by low, stimulatory (8 mM)  concentrations of glucose
Fig. 5). These observations are thus compatible with earlier studies
25–27] demonstrating a role for GLP-1 in controlling Ca2+ dynam-
cs in -cells. More noticeable was the complete lack of any observ-
ble effect of GLP-1 on Ca2+ dynamics induced by both intermediate
11 mM)  and elevated (17 mM)  glucose concentrations, despite
arked increases in insulin secretion under the same conditions
Figs. 4 and 5). This ﬁnding suggests that at these high glucose
oncentrations GLP-1 principally acts by potentiation of glucose-
nduced insulin secretion and does not involve an increase in
lectrical activity or [Ca2+]i. However, at lower glucose concentra-
ions (8 mM),  GLP-1 elicited an increase in [Ca2+]i that likely reﬂects
timulation of electrical activity. Thus, the mode of action of GLP-1
iffers depending on the glucose concentration. Importantly, elim-
nation of Tpcn2 had no effect on GLP-1-induced changes in Ca2+ ﬁgure legend, the reader is referred to the web version of this article.)
dynamics or insulin secretion at any of the glucose concentrations
tested, arguing against an absolute requirement for these channels
in NAADP-mediated effects.
4.3. Overall conclusions
The present studies demonstrate that TPC2 is not absolutely
required for normal glucose or incretin responses in pancreatic
-cells. We suggest that there may be signiﬁcant overlap, and
therefore functional redundancy, between two  pore channel sub-
types (Tpcn1 and Tpcn2),  allowing NAADP-dependent actions to
persist. The present studies also suggest that the actions of GLP-1
on insulin secretion occur predominantly, though not exclusively,
via mechanisms which are independent of changes in [Ca2±]i.
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